Evidence map›Paper›PMID 23133403›Full record

ArticlePLoS genetics2012

A dominantly acting murine allele of Mcm4 causes chromosomal abnormalities and promotes tumorigenesis.

Bruce N Bagley, Thomas M Keane, Vilena I Maklakova, Jonathon G Marshall, Rachael A Lester, Michelle M Cancel, Alex R Paulsen, Laura E Bendzick, Raha A Been, Scott C Kogan and 4 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. Mcm2 hypomorph leads to acute leukemia or hematopoietic stem cell failure, dependent on genetic context.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. ADAR1-Mediated RNA Editing and Its Role in Cancer.Frontiers in cell and developmental biology · 2022
    Review
  8. Increased expression ofJournal of gastrointestinal oncology · 2021
    Article
  9. Article
  10. Targeting ATR in cancer.Nature reviews. Cancer · 2018
    Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

Bruce N BagleySchool of Pharmacy and UW Carbone Cancer Center, University of Wisconsin Madison, Madison, WI, USA.
Thomas M Keane
Vilena I Maklakova
Jonathon G Marshall
Rachael A Lester
Michelle M Cancel
Alex R Paulsen
Laura E Bendzick
Raha A Been
Scott C Kogan
Robert T Cormier
Christina Kendziorski
David J Adams
Lara S Collier
University of Wisconsin–Madison · USUniversity of Minnesota · USWellcome Sanger Institute · GBUniversity of California, San Francisco · USUniversity of Minnesota, Duluth · USUniversity of Wisconsin Carbone Cancer Center · US

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Nihal Ahmad · 1985 to 2026
$142.6M
Statistical methods for spatial RNA sequencing experimentsR01GM102756 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI KENDZIORSKI, CHRISTINA · 2012 to 2024
$3.8M
Sleeping Beauty for cancer gene discoveryK01CA122183 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI COLLIER, LARA S · 2006 to 2010
$729k
Sdl: a model for lymphocytic leukemiaR03CA137751 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI COLLIER, LARA S · 2008 to 2009
$149k
Cancer Research UKMedical Research Council G0800024NCI NIH HHS K01 CA122183NCI NIH HHS K01CA122183NCI NIH HHS P30 CA014520NCI NIH HHS P30CA014520NCI NIH HHS R03 CA137751NCI NIH HHS R03CA137751NIGMS NIH HHS GM102756NIGMS NIH HHS R01 GM102756Wellcome Trust
6 · The paper itself

Abstract

Here we report the isolation of a murine model for heritable T cell lymphoblastic leukemia/lymphoma (T-ALL) called Spontaneous dominant leukemia (Sdl). Sdl heterozygous mice develop disease with a short latency and high penetrance, while mice homozygous for the mutation die early during embryonic development. Sdl mice exhibit an increase in the frequency of micronucleated reticulocytes, and T-ALLs from Sdl mice harbor small amplifications and deletions, including activating deletions at the Notch1 locus. Using exome sequencing it was determined that Sdl mice harbor a spontaneously acquired mutation in Mcm4 (Mcm4(D573H)). MCM4 is part of the heterohexameric complex of MCM2-7 that is important for licensing of DNA origins prior to S phase and also serves as the core of the replicative helicase that unwinds DNA at replication forks. Previous studies in murine models have discovered that genetic reductions of MCM complex levels promote tumor formation by causing genomic instability. However, Sdl mice possess normal levels of Mcms, and there is no evidence for loss-of-heterozygosity at the Mcm4 locus in Sdl leukemias. Studies in Saccharomyces cerevisiae indicate that the Sdl mutation produces a biologically inactive helicase. Together, these data support a model in which chromosomal abnormalities in Sdl mice result from the ability of MCM4(D573H) to incorporate into MCM complexes and render them inactive. Our studies indicate that dominantly acting alleles of MCMs can be compatible with viability but have dramatic oncogenic consequences by causing chromosomal abnormalities.

Indexed as

Chromosome AberrationsAllelesAnimalsCell Transformation, NeoplasticChromosomal InstabilityDisease Models, AnimalDNA HelicasesDNA ReplicationGenes, DominantHumansMiceMinichromosome Maintenance Complex Component 4MutationPrecursor T-Cell Lymphoblastic Leukemia-LymphomaReceptor, Notch1ReticulocytesDNA HelicasesMcm4 protein, mouseMinichromosome Maintenance Complex Component 4Notch1 protein, mouseReceptor, Notch1

Identifiers

PMID23133403
PMCPMC3486839
OpenAlexW2091309595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.